Catalent to More than Double U.S. Bioreactor Capacity

Contract manufacturer and pharmaceutical services company Catalent Pharma Solutions (Somerset, NJ) says it plans to more than double its bioreactor capacity by adding a 1,000-liter bioreactor train at its cGMP facility at Middleton, WI. The expansion is set to be installed by 2009. Doubling up: A bioreactor train is added at Middleton, WI site. The Middleton site currently includes a 43,000-sq-ft building, housing cGMP manufacturing and quality-control labs as well as R&D molecule and cell biology labs. Current clinical trial manufacturing is limited to 200...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers